Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. 19828698 Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, Marti GE, Albitar M, Ghia P, Rajkumar SV, Landgren O Blood 2009 PLCO
Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 19254935 Gren L, Broski K, Childs J, Cordes J, Engelhard D, Gahagan B, Gamito E, Gardner V, Geisser M, Higgins D, Jenkins V, Lamerato L, Lappe K, Lowery H, McGuire C, Miedzinski M, Ogden S, Tenorio S, Watt G, Wohlers B, Marcus P Clin Trials 2009 PLCO
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. 19404219 Tammemagi MC, Freedman MT, Pinsky PF, Oken MM, Hu P, Riley TL, Ragard LR, Berg CD, Prorok PC J Thorac Oncol 2009 PLCO
Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. 19644707 Yeager M, Deng Z, Boland J, Matthews C, Bacior J, Lonsberry V, Hutchinson A, Burdett LA, Qi L, Jacobs KB, Gonzalez-Bosquet J, Berndt SI, Hayes RB, Hoover RN, Thomas G, Hunter DJ, Dean M, Chanock SJ Hum. Genet. 2009 PLCO
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. 19179464 Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV Blood 2009 PLCO
Effect of obesity at age 20 and 50 on development of prostate cancer in the PLCO Cancer Screening trial. Grubb RL, Black A, Church TR, Hickey T, Izmirlian G, Riley T, Prorok PC, Berg CD, Crawford ED, Andriole GL J Urol 2009 PLCO
Pre-biopsy prostate cancer nomograms based upon serial PSA screening data in the PLCO trial with verfication bias correction. Izmirlian G, Grubb RL, Black A, Prorok PC, Berg CD, Crawford ED, Andriole GL, Kibel AS J Urol 2009 PLCO
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. 19124512 McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, Riboli E, Barricarte A, Berg CD, Bergland G, Bingham S, Brustad M, Bueno-de-Mesquita HB, Burdette L, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Cox DG, Dossus L, Feigelson HS, Haiman… Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). 19574343 Ahn J, Schumacher FR, Berndt SI, Pfeiffer R, Albanes D, Andriole GL, Ardanaz E, Boeing H, Bueno-de-Mesquita B, Chanock SJ, Clavel-Chapelon F, Diver WR, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hoover RN, Kolonel LN, Kraft P,… Hum. Mol. Genet. 2009 PLCO
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. 19383797 Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Ca… Proc. Natl. Acad. Sci. U.S.A. 2009 PLCO
Identification of a new prostate cancer susceptibility locus on chromosome 8q24. 19767755 Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, Yu K, Hutchinson A, Wang Z, Amundadottir L, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-T… Nat. Genet. 2009 PLCO
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. 19767753 Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Cleme… Nat. Genet. 2009 PLCO
Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. 19258474 Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL, Leitzmann M, Männistö S, Marshall JR, McCullough ML, Miller AB, Reding D… Cancer Epidemiol. Biomarkers Prev. 2009 PLCO
Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. 19242102 Cruz-Correa M, Zhao R, Oviedo M, Bernabe RD, Lacourt M, Cardona A, Lopez-Enriquez R, Wexner S, Cuffari C, Hylind L, Platz E, Cui H, Feinberg AP, Giardiello FM Epigenetics 2009 PLCO
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. 18505967 Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM, Hayes RB, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team J. Natl. Cancer Inst. 2008 PLCO
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). 18596909 Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Cox DG, Dorronsoro M, Dossus L, Haiman CA, Hankinson SE, Henderson BE, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Linseisen J, L… PLoS ONE 2008 PLCO
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. 18791929 Erichsen HC, Peters U, Eck P, Welch R, Schoen RE, Yeager M, Levine M, Hayes RB, Chanock S Nutr Cancer 2008 PLCO
The natural history of aberrant crypt foci. 18178205 Schoen RE, Mutch M, Rall C, Dry SM, Seligson D, Umar A, Pinsky P Gastrointest. Endosc. 2008 PLCO
Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests. 18416950 Baker SG, Kramer BS J Med Screen 2008 PLCO
The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. 18586313 Johnson CC, Kessel B, Riley TL, Ragard LR, Williams CR, Xu JL, Buys SS, Prostate, Lung, Colorectal and Ovarian Cancer Project Team Gynecol. Oncol. 2008 PLCO